Navigation Links
Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets

SYDNEY and WESTMINSTER, Colo., June 20, 2013 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and US-based Surefire Medical today announced a sales and marketing partnership to distribute Surefire's range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets.

The agreement will see Sirtex exclusively distribute the Surefire Medical range of products in the company's rapidly growing Asia Pacific markets including Australia.

Sirtex reported a 30 per cent growth in dose sales of its targeted radiation treatment for liver cancer in the Asia Pacific region at the end of the third quarter ended 31 March 2013.

Rapidly growing Surefire Medical has received regulatory approval in the U.S., Europe, Canada and New Zealand.  Its first-in-class infusion systems are used by numerous top-ranked cancer centers and hospitals in these markets.

The Surefire Infusion System has been designed to enhance the accuracy and delivery of drugs directly to tumors.  Surefire products use a patented microcatheter with an expandable tip. When deployed, the tip dynamically responds to flow conditions to enable more of the embolic agent to reach the intended destination while reducing non-target delivery compared to traditional infusion systems.

The ability to more safely and efficiently deliver embolic agents directly to target tumors marks a significant advance in radiation oncology procedures and in the treatment of liver cancer.

Sirtex Medical Asia Pacific Chief Executive Officer Dr. Burwood Chew said, "Sirtex is constantly looking for new ways to help our customers improve the outcomes of their patients with liver cancer.  We believe this distribution partnership will allow us to provide interventional radiologists and oncologists with a wider range of options that may potentially lead to improved patient outcomes, which is our shared goal."

Surefire Medical CEO Jim Chomas said, "A growing body of positive clinical evidence and the enthusiasm of our increasing user base at hospitals worldwide continue to prove the efficacy of the Surefire line of infusion systems.  The agreement with Sirtex enables our companies to jointly pursue more effective treatment for the rising worldwide incidence of liver cancer."

For further information please refer to and  

SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.

SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
2. Green Valley Drugs Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By Green Valley Drugs Due To Quality Control Concerns
3. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
4. GHX Selects MicroStrategy to Offer Healthcare Suppliers Enhanced Access to Distributed Medical-Surgical Market Data
5. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Cad Software
6. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Volpara Breast Density Software
7. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
8. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
9. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
10. Christopher Mennone Joins Surefire Medical Team As International Business Director
11. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
Post Your Comments:
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
Breaking Medicine News(10 mins):